holistic and proactive approach to pharmaceutical development. The concept promotes industry's understanding of the product and manufacturing process starting with product development, basically ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

The pharmaceutical industry ... From understanding the role of contract development and manufacturing organisations (CDMOs) to navigating the process of selecting the right partner, this article ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Pharmaceutical Intermediates MarketThe global pharmaceutical intermediates market is set for significant expansion, with revenue expected to grow from USD 36,620.2 million in 2025 to USD 57,031.9 ...

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical ...

analytical method development, manufacturing process optimization, and regulatory compliance . This expansion enables Vici to meet the evolving needs of its pharmaceutical and biotech clients ...

Accelerator™ Drug Development provides a customizable suite of manufacturing, clinical research and clinical supply chain services for emerging biotechs and large pharmaceutical companies at ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances Jabil's ...